# US 8,788,044 B2 · Systems and methods for tissue stimulation in medical treatment > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 8,788,044 B2 - Document ID: US8788044B2 - Status: Granted - Kind: B2 - Application number: 11/307,050 - Filed: 2006-01-20 - Published: 2006-07-06 - Granted: 2014-07-22 - Earliest claimed: 2005-01-21 - Applicants: Michael Sasha John - Inventors: Michael Sasha John - Web page: https://patentgrep.com/patent/US8788044B2 ## CPC - A61N 1/36178: {Burst or pulse train parameters} - A61N 1/36064: {Epilepsy} - A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease} - A61N 1/37235: {Aspects of the external programmer} - A61M 5/14276: {specially adapted for implantation} - A61M 5/172: electrical or electronic - A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure} - A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]} - A61N 1/0529: {Electrodes for brain stimulation} - A61N 1/36071: {Pain} - A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)} - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract Stimulation treatments for various medical disorders, such as neurological disorders, comprise novel systems, strategies, and methods for providing TMS, electrical, magnetic, optical and other stimulation. Some stimulation methods comprise varying the stimulation parameters to improve the therapeutic efficacy of stimulation, and decrease risk of habituation and side-effects such as interference with normal brain, sensory, motor, and cognitive processes. The creation, and subsequent variation, of stimulation parameters can use sensed data in order to match, adjust, or avoid matching characteristics of the stimulation therapy relative to certain endogenous brain activities. Novel methods are described for choosing, creating and subsequently stimulating with partial signals which summate to produce therapeutic vector fields having unique temporal patterns and low-or high-frequency spectral content. ## Claims ### Claim 1 A method of treating a brain disorder comprising; a. operating a patient programmer device which is external to the patient in order to program a programmable medical treatment device with parameter values for a treatment protocol and selecting in the treatment protocol a therapeutic stimulation signal comprising spectral energy primarily below a first selected frequency of 20 Hz; b. creating a set of two or more partial signals wherein each of the partial signals comprises spectral energy of primarily above a second selected frequency of 20 Hz , and wherein the vector addition of said partial signals results in a vector field signal which is approximately equivalent to the therapeutic stimulation signal; and, c. applying the two or more partial signals, according to the treatment protocol, at two or more implanted stimulation conduits to stimulate approximately a selected neural target region with the vector field signal d. wherein stimulation is provided for the treatment of epilepsy. ### Claim 2 (depends on 1) The method of claim 1 wherein the therapeutic stimulation signal is selected due to one or more of: evaluation of sensed data; availability of one or more sets of partial signals stored in a database; and, the treatment protocol. ### Claim 3 (depends on 1) The method of claim 1, wherein the vector field signal, or a rectified transformation of the vector field signal, comprises spectral energy of primarily below the second selected frequency. ### Claim 4 (depends on 3) The method of claim 3 wherein the first selected frequency is 20 Hz and the second selected frequency is 20 Hz. ### Claim 5 (depends on 4) The method of claim 4, wherein stimulation is provided for the treatment of epilepsy. ### Claim 6 (depends on 1) The method of claim 1, wherein the partial signals each contain spectral energy of primarily above a first selected frequency of 20 Hz and the vector field signal comprises spectral energy of primarily below a second selected frequency of 20 Hz, said first frequency being further selected to be at least twice the second selected frequency. ### Claim 7 (depends on 1) The method of claim 1, wherein the partial signals are pulse waveforms having non-burst characteristics relative to the burst characteristics of the vector field signal. ### Claim 8 (depends on 1) The method of claim 1 wherein the stimulation signals are pulse trains containing different pulse shapes than those which are created by the vector field signal. ### Claim 9 (depends on 1) The method of claim 1, wherein each partial signal is substantially unique in a portion of the spectral or temporal characteristics. ### Claim 10 (depends on 1) The method of claim 1 wherein each partial signal is selected according to at least one of: the voltage and the current at which it will be provided. ### Claim 11 (depends on 1) The method of claim 1 wherein creating at least two partial signals comprises submitting the stimulation signal to a circuit, algorithm, or digital signal processor which is designed to create two or more partial signals using at least one of the following steps; a. adding at least two interference signals to a base signal, wherein the summation of said interference signals leads to approximately a null signal; b. iteratively subtracting at least one partial signal from a base stimulation signal in order to produce at least two partial signals; c. iteratively filtering the stimulation signal in order to produce at least two partial signals; d. selecting two or more partial signals from sets of signals stored in a database. ### Claim 12 (depends on 1) The method of claim 1 wherein the vector field signal primarily produces one of: excitatory stimulation and inhibitory stimulation, and said at least one of the partial signals produces a stimulation effect in non-target tissue that is opposite to that of said vector field signal. ### Claim 13 (depends on 1) The method of claim 1 wherein said vector field signal is selected to produces a desired change in the firing of neurons in at least approximately one target area, and said partial signals are selected to be different from particular EEG rhythms which have been measured in the a patient. ### Claim 14 (depends on 1) The method of claim 1, wherein each of the partial signals are adjusted to have spectral characteristics so that these signals have frequencies that exceed the chronaxie of the target tissue with respect to the strength of the signals, whereby each of the partial signals do not cause stimulation of the target tissue. ### Claim 15 (depends on 1) The method of claim 1 wherein said therapeutic stimulation signal serves as a base signal which is divided into two or more partial-signals, and stimulation with said two or more partial-signals occurs at three or more locations, at two or more sequential durations in time. ### Claim 16 (depends on 1) The method of claim 1, further including the step of d. adjusting the partial signals so that the net stimulation signal integrated across time approximates said base signal with respect to at least one of: energy transfer characteristics of the contacts in relation to a neural target region; energy transfer through tissue; entrainment properties of the neural tissue; and, impedance values. ### Claim 17 (depends on 1) The method of claim 1, further including steps of; d. iteratively performing steps ‘b’ and ‘c’ a number of times; e. selecting sets of two or more partial signals that provided successful treatment and rejecting sets of two or more partial signals that failed to provide successful treatment; and, f. providing the successful partial signals during subsequent treatment. ### Claim 18 (depends on 1) The system of claim 1 wherein the stimulation subsystem includes at least two transcranial magnetic stimulation coils configured to provide stimulation and wherein the stimulation is pulsed or modulated primarily above 10 Hz, while inducing a field stimulation signal having spectral energy below 10 Hz. ### Claim 19 (depends on 1) The method of claim 1, wherein the field summation signal promotes the entrainment of a neural target region at two or more frequencies primarily between approximately 0.5 and 200 Hz. ### Claim 20 (depends on 1) The method of claim 1 wherein the partial signals are each assigned to selected contacts, and said signals are subsequently reassigned to selected contacts according to at least one of the following: after a specified amount of time; due to the detection of an event; in response to sensed data; according to the treatment protocol. ### Claim 21 (depends on 1) A method of treatment of claim 1, wherein said two or more stimulation conduits are at least one of: different leads connected to different implantable devices optical stimulators; sonic stimulators; and magnetic coils. ### Claim 22 (depends on 1) The method of claim 1 wherein the two or more partial signals are iteratively selected from a database or are adjusted until therapy can be provided and side-effects attenuated to provide improved patient comfort. ### Claim 23 A system for providing enhanced targeted brain stimulation to a patient's brain, the system comprising; a. an implantable device having a stimulation subsystem coupled to at least two stimulation conduits, wherein the stimulation subsystem provides at least two unique stimulation signals to the conduits, said signals each having the majority of their spectral energy within a first band, said signals configured to produce a field summation signal which when rectified by a mathematical transformation has the majority of its energy within a second band primarily below a frequency of 20 Hz; b. a control subsystem having a processor which is operative to cause the stimulation subsystem to initiate application of the desired field summation signal which remains stable while the stimulation signals rove over time; and, c. at least two stimulation conduits located in sufficiently close proximity to enable said field summation to occur; d. an external patient programmer configured to communicate with the implantable device to program said implantable device in order to adjust the characteristics of the stimulation signals and to adjust at least one parameter related to how these rove over time. ### Claim 24 (depends on 23) The system of claim 23, wherein the spectral energy within a first band is defined as spectral energy above approximately 20 Hz. ### Claim 25 (depends on 23) The system of claim 23, wherein the spectral energy within a first band, is defined as spectral energy relative to approximately a target frequency and wherein the spectral energy within of a second band is defined as spectral energy relative to a second target frequency. ### Claim 26 (depends on 25) The system of claim 25, wherein the first and second bands are defined according to at least one of the following; a. The first spectral energy within a first band, is defined as spectral energy above a first target frequency of 20 Hz and the spectral energy within of a second band is defined as spectral energy below a second target frequency of 20 Hz; b. The first spectral energy within a first band, is defined as spectral energy above a first target frequency of 100 Hz and the spectral energy within of a second band is defined as spectral energy below a second target frequency of 20 Hz; c. The first spectral energy within a first band, is defined as spectral energy below a first target frequency of 200 Hz and the spectral energy within of a second band is defined as spectral energy above a second target frequency of 300 Hz; d. The first spectral energy within a first band, is defined as spectral energy below a first target frequency of 500 Hz; and, e. The spectral energy within a second band, is defined as spectral energy modulated at between 0.5 and 300 Hz. ### Claim 27 (depends on 23) The system of claim 23 which additionally comprises at least one of the following; a. a sensing subsystem configured to sense data from at least one sensor; b. a sensing subsystem containing a detection subsystem, wherein the detection subsystem is operative to receive and process sensed data received by said sensing subsystem; and, c. a sensing subsystem which communicates with said control subsystem, said control subsystem being operative to cause the stimulation subsystem to provide responsive stimulation according to the treatment protocol. ### Claim 28 (depends on 27) The system of claim 27 wherein the sensor and stimulation conduit are configured to sense and stimulate from different regions of the patient's brain. ### Claim 29 (depends on 27) The system of claim 27, wherein the control subsystem controls at least one of the following: the stimulation subsystem; the sensing subsystem; the detection subsystem of the sensing subsystem; a signal generation module for determining the stimulation signals that are applied to the stimulation electrodes to produce the vector field summation signal. ### Claim 30 (depends on 23) The stimulation subsystem of claim 23 which provides at least two stimulation signals to the conduits to produce a field summation signal that is substantially modulated at one or more frequencies which are therapeutic to the target brain tissue. ### Claim 31 (depends on 23) The stimulation subsystem of claim 23 which provides at least two stimulation signals to the stimulation conduits to produce a field summation, wherein the stimulation subsystem is configured to provide stimulation signals that are simultaneously altered so that the spectral composition of the stimulation signals changes and wherein the field summation signal remains substantially unchanged. ### Claim 32 (depends on 23) The stimulation subsystem of claim 23, wherein the stimulation subsystem is configured to adjust at least one of the stimulation signals according to at least one of: periodically; at random intervals; continuously; in response to sensed data; accordingly to a predetermined treatment schedule; and, in response to a neurological event. ### Claim 33 (depends on 23) The stimulation subsystem of claim 23 which provides at least two stimulation signals to the stimulation conduits to produce a field summation, wherein at least one of: the phase; the modulation rate; and, the spectral composition of a band of energy is different for each of the two stimulation signals. ### Claim 34 (depends on 23) The stimulation subsystem of claim 23 wherein the subsystem contains a signal generation module that generates at least two stimulation signals based upon calculations made upon data contained in a database which includes information about at least one of: the number of stimulation conduits activated during stimulation; the 2-dimensional positions of leads; the 2-diminsional inter-lead distances; the 3-dimensional positions of leads; the 3-dimensional inter-lead distances; the bipolar or unipolar activation mode for each lead; the 3-dimensional positions of grounds; and, the impedances of the conduits. ### Claim 35 (depends on 23) The stimulation subsystem of claim 23 wherein the subsystem contains a signal generation module that generates at least two stimulation signals based upon calculations made upon data contained in a database in order to produce approximately the desired vector field summation signal in approximately the desired tissue. ### Claim 36 (depends on 23) The stimulation subsystem of claim 23 wherein the subsystem contains a signal generation module that generates at least two stimulation signals in response to sensed data, wherein the sensed data are used to shape the resulting field summation signal so that its adds primarily constructively or destructively with at least one signal in a selected frequency range of the endogenous EEG of the patient. ### Claim 37 (depends on 23) The stimulation subsystem of claim 23 wherein the selection and assignment of partial signals, or sets of partial signals, is determined based upon one or more characteristics of the treatment protocol such as the voltage and current level. ### Claim 38 (depends on 23) The system of claim 23 wherein the stimulation subsystem includes at least two magnetic stimulation coils configured to provide stimulation primarily directed to at least one of the following areas of a depressed patients brain; a. the frontal area; and; b. the frontal area lateralized either the left or right hemisphere. ### Claim 39 A method for providing enhanced targeted brain stimulation to a patient's brain, the method comprising: a. operating an external patient programmer to program an implanted stimulation subsystem according to a stimulation program which is to be implemented during stimulation; b. stimulating with the stimulation subsystem coupled to at least two stimulation conduits, wherein the stimulation subsystem provides at least two unique stimulation signals to the conduits, said signals each having the majority of their spectral energy within a first band, said signals configured to produce a field summation signal which when rectified has the majority of its energy within a second band, said second band being below 20 Hz; c. operating a processor of a control subsystem which controls the stimulation subsystem to cause the stimulation subsystem to initiate application of the desired field summation signal; and d. locating the at least two stimulation conduits so that these are in sufficiently close proximity to enable said field summation to occur; e. wherein the two unique stimulation signals are iteratively selected from a database or are adjusted until at least one of the following occurs: i. therapy induces therapeutic benefit that is satisfactory; and, ii. therapy induced side effects are attenuated below a level which is determined to be satisfactory to providing therapy with a desired level of patient comfort. ### Claim 40 (depends on 39) The method of claim 39, wherein the first and second bands are defined so that the two unique stimulation signals contain spectral energy above approximately 20 Hz and the field summation signal contains spectral energy between approximately 0.5 and 20 Hz. ### Claim 41 (depends on 39) The method of claim 39 which additionally comprises at least one of the following; a. performing sensing with a sensing subsystem configured to sense data from at least one sensor; b. performing sensing with a sensing subsystem containing a detection subsystem, wherein the detection subsystem is operated to receive and process sensed data received said sensing subsystem; and, c. performing sensing with a sensing subsystem which communicates with said control subsystem, said control subsystem being operative to cause the stimulation subsystem to provide responsive stimulation according to the treatment protocol. ### Claim 42 (depends on 41) The method of claim 41, wherein the control subsystem is operated to control at least one of the following: the stimulation subsystem; the sensing subsystem; the detection subsystem; and, a signal generation module for determining the stimulation signals that are applied to the stimulation electrodes to produce the field summation signal. ### Claim 43 (depends on 39) The method of claim 39, which provides at least two stimulation signals to the conduits to produce a field summation that is substantially modulated at one or more frequencies which are therapeutic to the target brain tissue. ### Claim 44 (depends on 39) The method of claim 39, including providing at least two unique stimulation signals to the stimulation conduits to produce a field summation, wherein the stimulation signals are simultaneously altered so that the spectral composition of the stimulation signals changes and wherein the field summation signal remains substantially unchanged. ### Claim 45 (depends on 39) The method of claim 39 wherein the stimulation subsystem is further configured to operate so that at least one of the unique stimulation signals is altered according to at least one of: periodically; at random intervals; continuously; in response to sensed data; accordingly to a predetermined treatment schedule; and, in response to a neurological event. ### Claim 46 (depends on 39) The method of claim 39 wherein the stimulation subsystem is further configured to operate so that at least two unique stimulation signals which are provided to the stimulation conduits to produce a field summation, are adjusted so that at least one of: the phase; the modulation rate; and, the spectral composition of a band of energy is different for each of the two stimulation signals. ### Claim 47 (depends on 39) The method of claim 39 wherein the stimulation subsystem is further configured with a signal generation module that generates at least two stimulation signals based upon calculations made upon data contained in a database which includes information about at least: the number of leads activated during stimulation; the 2-dimensional positions of leads; the 2-diminsional inter-lead distances; the 3-dimensional positions of leads; the 3-dimensional inter-lead distances; the bipolar or unipolar activation mode for each lead; the 3-dimensional positions of grounds; and, impedances of the leads. ### Claim 48 (depends on 39) The method of claim 39 wherein the subsystem contains a signal generation module that generates at least two stimulation signals based upon calculations made upon data contained in a database in order to produce approximately the desired field summation signal in approximately the desired tissue. ### Claim 49 (depends on 39) The method of claim 39 further including the step of obtaining sensed data from a sensing subsystem, wherein the stimulation subsystem contains a signal generation module that generates at least two stimulation signals in response to the sensed data, wherein the sensed data are used to adjust the resulting field summation signal so that its adds primarily constructively or destructively with at least one selected frequency of the endogenous EEG of the patient. ### Claim 50 (depends on 39) The method claim 39 wherein the selection and assignment of partial signals, or sets of partial signals, to at least two or more stimulation conduits is determined based upon one or more characteristics of the treatment protocol such as overall voltage and current level. ### Claim 51 A method for treating a patient with targeted stimulation comprising; a. operating an external patient programmer to select a stimulation signal which stimulates a target region to produce therapeutic benefit; b. creating two or more sets of two or more partial signals which will create a vector field approximately identical to the stimulation signal when these are applied at selected contacts; c. applying each set of the sets of partial signals; d. selecting at least two sets of partial signals which contain advantageous characteristics; and, e. using the at least two sets of partial signals to provide therapeutic stimulation in the treatment of epilepsy. ### Claim 52 (depends on 51) The method of claim 51, wherein the advantageous characteristics are at least one of: not producing side-effects; minimizing side-effects; and, providing for increased transmission to a target site. ### Claim 53 (depends on 51) The method of claim 51, wherein targeted stimulation is provided to human tissue, said tissue being at least one of the following: the brain; spinal chord; peripheral nerves; vagus nerves; tissue related to sexual organs; tissue of the digestive tract; cardiac tissue. ### Claim 54 (depends on 51) The method of claim 51, wherein the advantageous characteristics are at least one of: stimulating non-target tissue to produce effects that are different than those produced in target tissue; stimulating target tissue in a manner which produces effects opposite to that produced in target tissue; providing improved energy transmission; providing therapeutic modification of neurochemical levels; providing therapeutic modification of tissue permeability; and stimulating non-target tissue in a manner that does not produce inhibition of the non-target tissue. ### Claim 55 A method of treating a brain disorder comprising; Implanting a neurostimulator in a patient with a seizer disorder in order to provide for treatment of the disorder; Operating an external patient programmer device which communicates with the implantable neurostimulator in order to provide for adjusting the treatment, operating the neurostimulator to provide a treatment which is a vector stimulation field that is created by the summation of at least two partial stimulation signals, wherein the partial stimulation signals are designed to have a signal component, that approximately adds constructively in the vector stimulation field, and a noise component which approximately adds destructively in the vector stimulation field, and wherein stimulating with the vector stimulation signal rather than the partial stimulation signals would produce an unwanted side effect. ### Claim 56 (depends on 55) The method of claim 55, wherein adjusting the treatment includes adjusting of the vector stimulation field by adjusting at least one of the at least two partial stimulation signals. ### Claim 57 (depends on 55) The method of claim 55, wherein adjusting of the treatment includes adjusting the at least two partial stimulation signals so that the vector stimulation field remains approximately constant. ### Claim 58 (depends on 55) The method of claim 55, wherein adjusting of the treatment includes adjusting the at least two partial stimulation signals so that the adjustment of a first of the at least two partial stimulation signals causes the automatic adjustment of a second of the at least two partial stimulation signals. ### Claim 59 (depends on 55) The method of claim 55, wherein adjusting of the treatment includes adjusting according to a least one pre-set value that has be previously entered into a database. ### Claim 60 (depends on 55) The method of claim 55, wherein adjusting of the treatment occurs according to patient input that is inputted to the programmer, the programmer further configured to allow for patient selection and adjustment of partial stimulation signals. ### Claim 61 (depends on 55) The method of claim 55, wherein adjusting of the vector stimulation field includes adjusting at least one of: strength; spectral and temporal characteristics; shape; direction; orientation; and, position.